Vaxart, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Vaxart, Inc. (VXRT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 3.61 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-06
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-06-30 was 1.11M shares, a 180.29% increase year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2026-03-31 was 2.50M shares, a 3938.34% increase year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 173.01K shares, a 82.95% decline year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 792.22K shares, a 413.38% increase year-over-year.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 1.99M shares, a 1079.01% increase from fiscal 2022.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 168.94K shares, a 210.60% increase from fiscal 2021.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2021 was 54.39K shares, a 5.82% decline from fiscal 2020.
- Vaxart, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2020 was 57.75K shares, a 77.08% decline from fiscal 2019.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | 1.11M shares derived: 10-Q 6 month − S-1 3 month · filed 2026-08-06 | 3.61M shares 10-Q · filed 2026-08-06 | 3.79M shares derived: sum of 3 quarters · filed 2026-08-06 | 4.58M shares derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | 2.50M shares S-1 · filed 2026-05-08 | 2.67M shares derived: sum of 2 quarters · filed 2026-05-08 | 3.47M shares derived: sum of 3 quarters · filed 2026-05-08 | 3.86M shares derived: sum of 4 quarters · filed 2026-05-08 | |
| 2025-12-31 | 173.01K shares derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | 965.23K shares derived: sum of 2 quarters · filed 2026-05-08 | 1.36M shares derived: sum of 3 quarters · filed 2026-05-08 | 1.42M shares S-1 · filed 2026-05-08 | |
| 2025-09-30 | 792.22K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | 1.19M shares derived: sum of 2 quarters · filed 2025-11-13 | 1.25M shares 10-Q · filed 2025-11-13 | 2.27M shares derived: sum of 4 quarters · filed 2026-05-08 | |
| 2025-06-30 | 396.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 458.90K shares 10-Q · filed 2025-08-13 | 1.47M shares derived: sum of 3 quarters · filed 2026-05-08 | 1.63M shares derived: sum of 4 quarters · filed 2026-05-08 | |
| 2025-03-31 | 61.94K shares 10-Q · filed 2025-05-13 | 1.08M shares derived: sum of 2 quarters · filed 2026-05-08 | 1.23M shares derived: sum of 3 quarters · filed 2026-05-08 | 1.34M shares derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | 1.01M shares derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | 1.17M shares derived: sum of 2 quarters · filed 2026-05-08 | 1.28M shares derived: sum of 3 quarters · filed 2026-05-08 | 1.32M shares S-1 · filed 2026-05-08 | |
| 2024-09-30 | 154.32K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | 263.72K shares derived: sum of 2 quarters · filed 2024-11-13 | 306.34K shares 10-Q · filed 2024-11-13 | 368.03K shares derived: sum of 4 quarters · filed 2025-03-20 | |
| 2024-06-30 | 109.40K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 152.02K shares 10-Q · filed 2024-08-08 | 213.72K shares derived: sum of 3 quarters · filed 2025-03-20 | ||
| 2024-03-31 | 42.62K shares 10-Q · filed 2024-05-13 | 104.31K shares derived: sum of 2 quarters · filed 2025-03-20 | |||
| 2023-12-31 | 61.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 1.99M shares 10-K · filed 2025-03-20 | |||
| 2023-09-30 | 1.93M shares 10-Q · filed 2023-11-02 | ||||
| 2023-03-31 | 1.87M shares 10-Q · filed 2023-08-03 | 654.78K shares 10-Q · filed 2023-05-04 | 1.97M shares derived: sum of 2 quarters · filed 2024-03-14 | 2.00M shares derived: sum of 3 quarters · filed 2024-03-14 | |
| 2022-12-31 | 97.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 130.00K shares derived: sum of 2 quarters · filed 2024-03-14 | 168.94K shares 10-K · filed 2024-03-14 | ||
| 2022-09-30 | 32.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 71.70K shares 10-Q · filed 2022-11-09 | |||
| 2022-06-30 | 38.93K shares 10-Q · filed 2022-08-08 | ||||
| 2021-12-31 | 18.07K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | 20.43K shares derived: sum of 2 quarters · filed 2023-03-15 | 50.25K shares derived: sum of 3 quarters · filed 2023-03-15 | 54.39K shares 10-K · filed 2023-03-15 | |
| 2021-09-30 | 2.35K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 32.18K shares derived: sum of 2 quarters · filed 2021-11-04 | 36.31K shares 10-Q · filed 2021-11-04 | 36.31K shares derived: sum of 4 quarters · filed 2022-02-24 | |
| 2021-06-30 | 29.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 33.96K shares 10-Q · filed 2021-08-05 | 33.96K shares derived: sum of 3 quarters · filed 2022-02-24 | 34.56K shares derived: sum of 4 quarters · filed 2022-02-24 | |
| 2021-03-31 | 4.14K shares 10-Q · filed 2021-05-06 | 4.14K shares derived: sum of 2 quarters · filed 2022-02-24 | 4.74K shares derived: sum of 3 quarters · filed 2022-02-24 | 10.68K shares derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 604.00 shares derived: sum of 2 quarters · filed 2022-02-24 | 6.54K shares derived: sum of 3 quarters · filed 2022-02-24 | 57.75K shares 10-K · filed 2022-02-24 | |
| 2020-09-30 | 604.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 6.54K shares derived: sum of 2 quarters · filed 2020-11-12 | 57.75K shares 10-Q · filed 2020-11-12 | 105.74K shares derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | 5.94K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 57.15K shares 10-Q · filed 2020-08-06 | 105.14K shares derived: sum of 3 quarters · filed 2022-02-24 | 204.61K shares derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | 51.21K shares 10-Q · filed 2020-05-12 | 99.20K shares derived: sum of 2 quarters · filed 2022-02-24 | 198.66K shares derived: sum of 3 quarters · filed 2022-02-24 | 280.48K shares derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | 47.99K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | 147.46K shares derived: sum of 2 quarters · filed 2022-02-24 | 229.27K shares derived: sum of 3 quarters · filed 2022-02-24 | 252.01K shares 10-K · filed 2022-02-24 | |
| 2019-09-30 | 99.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | 181.28K shares derived: sum of 2 quarters · filed 2019-11-12 | 204.02K shares 10-Q · filed 2019-11-12 | 242.25K shares derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | 81.81K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 104.55K shares 10-Q · filed 2019-08-08 | 142.78K shares derived: sum of 3 quarters · filed 2021-02-25 | 165.11K shares derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | 22.74K shares 10-Q · filed 2019-05-09 | 60.96K shares derived: sum of 2 quarters · filed 2021-02-25 | 83.30K shares derived: sum of 3 quarters · filed 2021-02-25 | 348.92K shares derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | 38.23K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 60.56K shares derived: sum of 2 quarters · filed 2021-02-25 | 326.18K shares derived: sum of 3 quarters · filed 2021-02-25 | 405.98K shares 10-K · filed 2021-02-25 | |
| 2018-09-30 | 22.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | 287.96K shares derived: sum of 2 quarters · filed 2018-11-13 | 367.75K shares 10-Q · filed 2018-11-13 | ||
| 2018-06-30 | 265.62K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | 345.42K shares 10-Q · filed 2018-08-10 | |||
| 2018-03-31 | 79.79K shares 10-Q · filed 2018-05-15 | ||||
| 2017-12-31 | 13.25K shares 10-K · filed 2019-02-06 | ||||
| 2017-06-30 | 106.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-01 | 277.24K shares 10-K · filed 2017-09-01 | |||
| 2017-03-31 | 170.70K shares 10-Q · filed 2017-05-08 | ||||
| 2012-09-30 | 100.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | 425.78K shares 10-Q · filed 2012-11-08 | |||
| 2012-06-30 | 325.25K shares 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |